Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis

References

• Ahmed OA, van Leeuwen W, Fahal A, . Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004; 4: 566–574.
   PubMed Web of Science ®Google Scholar
• Fahal A, Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 2004; 98: 3–11.
   PubMed Web of Science ®Google Scholar
• Ahmed OA, van de Sande WWJ, van Vianen W, . In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 2004; 48: 2742–2746.
   PubMed Web of Science ®Google Scholar
• Ameen M, Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol 2009; 34: 1–7.
   PubMed Web of Science ®Google Scholar
• Ahmed OA, Mukhtar MM, Kools-Sijmons M, . Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol 1999; 37: 3175–3178.
   PubMed Web of Science ®Google Scholar
• Mahgoub ES. The value of gel diffusions in the diagnosis of mycetoma. Trans R Soc Trop Med Hyg 1964; 58: 560–563.
   PubMedGoogle Scholar
• Ahmed A, van de Sande WWJ, Fahal A, . Management of mycetoma: Major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 2007; 20: 146–151.
   PubMed Web of Science ®Google Scholar
• van de Sande WWJ, Janse DJ, Hira V, . Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J Immunol 2006; 177: 1997–2005.
   PubMed Web of Science ®Google Scholar
• van de Sande WWJ, Fahal A, Tavakol M, . Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. Med Mycol 2010; 48: 959–968
   PubMed Web of Science ®Google Scholar
• Verkaik NJ, de Vogel CP, Boelens HA, . Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis 2009; 199: 625–632.
   PubMed Web of Science ®Google Scholar
• Fahal AH, el Toum EA, el Hassan AM, . The host tissue reaction to Madurella mycetomatis: new classification. J Med Vet Mycol 1995; 33: 15–17.
   PubMedGoogle Scholar
• El-hassan AM, Fahal A, El-hag I. The pathology of mycetoma. Sud Med J 1994; 32: 23–45.
   Google Scholar
• Fraenkel DG. The top genes: on the distance from transcript to function in yeast glycolysis. Curr Opin Microbiol 2003; 6: 198–201.
   PubMed Web of Science ®Google Scholar
• Pitarch J, Abian M, Carrascal M, . Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004; 4: 3084–3106.
   PubMed Web of Science ®Google Scholar
• Gil-Navarro I, Gil ML, Casanova M, . The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen. J Bacteriol 1997; 179: 4992–4999.
   PubMed Web of Science ®Google Scholar
• Gil ML, Villamon E, Monteagudo C . Clinical strains of Candida albicans express the surface antigen glyceraldehyde 3-phosphate dehydrogenase in vitro and in infected tissues. FEMS Immunol Med Microbiol 1999; 23: 229–234.
   Google Scholar
• Gozalbo D, Gil-Navarro I, Azorin I, . The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect Immun 1998; 66: 2052–2059.
   PubMed Web of Science ®Google Scholar
• Villamon E, Gozalbo D, Martinez JP . Purification of a biologically active recombinant glyceraldehyde 3-phosphate dehydrogenase from Candida albicans. FEMS Microbiol Lett 1999; 179: 61–65.
   Google Scholar
• Delgado ML, O'Connor JE, Azorin I, . The glyceraldehyde-3-phosphate dehydrogenase polypeptides encoded by the Saccharomyces cerevisiae TDH1, TDH2 and TDH3 genes are also cell wall proteins. Microbiology 2001; 147: 411–417.
   PubMedGoogle Scholar
• Pancholi V, Fischetti VA. A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med 1992; 176: 415–426.
   PubMed Web of Science ®Google Scholar
• Asif AR, Oellerich M, Amstrong VW, . Analysis of the cellular Aspergillus fumigatus proteome that reacts with sera from rabbits developing an acquired immunity after experimental aspergillosis. Electrophoresis 2010; 31: 1947–1958.
   PubMed Web of Science ®Google Scholar
• Marques HH, Zouain CS, Torres CB, . Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni. Immunobiology 2008; 213: 437–446.
   PubMed Web of Science ®Google Scholar
• Peng SY, Tsaihong JC, Fan PC . Diagnosis of schistosomiasis using ecombinant fructose-1,6-bisphosphate aldolase from a Formosan strain of Schistosoma japonicum. J Helminthol 2009; 83: 211–218.
   Google Scholar
• Swoboda RK, Bertram K, Hollander H, . Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis. Infect Immun 1993; 61: 4263–4271.
   PubMed Web of Science ®Google Scholar
• Ling E, Feldman G, Portnoi M, . Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 2004; 138: 290–298.
   PubMed Web of Science ®Google Scholar
• Pitarch A, Diez-Orejas R, Molero G, . Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics 2001; 1: 550–559.
   Google Scholar
• Pitarch A, Nombela C, Gil C. Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum. Mol Cell Proteomics 2011; 10: M110 004010.
   Google Scholar
• Xin H, Dziadek S, Bundle DR, . Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci USA 2008; 105: 13526–13531.
   PubMed Web of Science ®Google Scholar
• McCarthy JS, Wieseman M, Tropea J, . Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infect Immun 2002; 70: 851–858.
   PubMed Web of Science ®Google Scholar
• Marsh JJ, Lebherz HG. Fructose-bisphosphate aldolases: an evolutionary history. Trends Biochem Sci 1992; 17: 110–113.
   PubMed Web of Science ®Google Scholar